Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-02 · accession 0001061983-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $61.62 | -886 | 50.4K | -2% | -$54.6K |
| D | 2026-03-02 | 2026-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +886 | 51.3K | +2% | +$33.3K |
| D | 2026-03-02 | 2026-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -886 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 886 | $61.62 | 50,440 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | M | A | 886 | $37.63 | 51,326 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2026-03-02 | M | D | 886 | $0.00 | 0 | D | $37.63 · 2025-04-01 to 2032-03-01 | 886 Common Stock | (F1) This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. |